A preliminary study on machine learning-based evaluation of static and dynamic FET-PET for the detection of pseudoprogression in patients with IDH-wildtype glioblastoma
- Sprache
-
Englisch
- Identifier
-
1221366998
Beteiligte Personen und Organisationen
Kebir, Sied
Schmidt, Teresa
Weber, Matthias
Lazaridis, Lazaros
Galldiks, Norbert
Langen, Karl-Josef
Kleinschnitz, Christoph
Hattingen, Elke
Herrlinger, Ulrich
Lohmann, Philipp
Glas, Martin
Schmidt, Teresa
Weber, Matthias
Lazaridis, Lazaros
Galldiks, Norbert
Langen, Karl-Josef
Kleinschnitz, Christoph
Hattingen, Elke
Herrlinger, Ulrich
Lohmann, Philipp
Glas, Martin
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:54 MEZ
Beteiligte
- Kebir, Sied
- Schmidt, Teresa
- Weber, Matthias
- Lazaridis, Lazaros
- Galldiks, Norbert
- Langen, Karl-Josef
- Kleinschnitz, Christoph
- Hattingen, Elke
- Herrlinger, Ulrich
- Lohmann, Philipp
- Glas, Martin
Ähnliche Objekte (12)
A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma
Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression
Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients
Pet/mri radiomics in patients with brain metastases
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement
Use of advanced neuroimaging and artificial intelligence in meningiomas
Case Report: Disruption of Resting-State Networks and Cognitive Deficits After Whole Brain Irradiation for Singular Brain Metastasis
A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma
Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression
Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients
Pet/mri radiomics in patients with brain metastases
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement
Use of advanced neuroimaging and artificial intelligence in meningiomas
Case Report: Disruption of Resting-State Networks and Cognitive Deficits After Whole Brain Irradiation for Singular Brain Metastasis
A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma
Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression
Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients
Pet/mri radiomics in patients with brain metastases
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement
Use of advanced neuroimaging and artificial intelligence in meningiomas